Alexion Pharmaceuticals is a biopharmaceutical company that specializes in the development and commercialization of biologic therapeutic products. The company's focus is on products for severe and life-threatening diseases such as hematologic, kidney, and neurologic diseases, transplant rejection, cancer, and autoimmune disorders. The business operates in various regions worldwide, including the United States, Europe, Latin America, Japan, and the Asia Pacific.
Alexion Pharmaceuticals's ticker is ALXN
The company's shares trade on the NASDAQ stock exchange
They are based in Boston, Massachusetts
There are 1001-5000 employees working at Alexion Pharmaceuticals
It is alexion.com
Alexion Pharmaceuticals is in the Healthcare sector
Alexion Pharmaceuticals is in the Biotechnology industry
The following five companies are Alexion Pharmaceuticals's industry peers: